The launch of a new over-the-counter product like Lumacyn Clarifying Mist directly to consumers is a significant development for Sonoma Pharmaceuticals. It indicates an expansion of their product line and a direct attempt to capture more of the consumer market. This could lead to increased revenue and profitability, which are key drivers of stock price appreciation. However, the actual impact will depend on the product's market acceptance and the effectiveness of the company's marketing strategy.